Journal of Histochemistry and Cytochemistry, Vol. 50, 1213-1217, September 2002, Copyright © 2002, The Histochemical Society, Inc.


ARTICLE

Endocytosis of Anti-CCK-B/Gastrin Receptor Antibody and Effect on Hepatoma Cell Lines

Mark Stubbsb, Korsa Khana, Susan A. Watsonc, Kay Savagea, Amar P. Dhillona, and Martyn E. Caplinb
a Departments of Histopathology
b Medicine
c Royal Free and University College Medical School, London, United Kingdom, and Cancer Studies Unit, Queens Medical Centre, University of Nottingham, Nottingham, United Kingdom

Correspondence to: Martyn E. Caplin, Gastroenterology and Hepatobiliary Medicine, Royal Free Hospital, Pond Street, London NW3 2QG, UK.


  Summary
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Immunotherapy has considerable potential in the treatment of cancer. Here we report on the uptake of an antibody raised against the CCK-B/Gastrin receptor (CCK-BR) by liver embryonic and liver tumor cell lines. In all five cell lines studied, expression of CCK-BR and uptake of labeled anti-CCK-BR antibody was observed. The labeled anti-CCK-BR antibody was localized in both the cytoplasm and nucleus of cells. In addition, we found a coincidence between the uptake of the labeled antibody by cells and the occurrence of apoptosis (cell death). The results suggest that antibodies directed against CCK-BR have potential for targeting and possibly destroying tumor cells bearing the receptor.

(J Histochem Cytochem 50:1213–1217, 2002)

Key Words: gastrin, CCK-B receptor, endocytosis, apoptosis, hepatocyte, tumor


  Introduction
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

The incidence of hepatocellular carcinoma (HCC) is increasing in the United States (Nair et al. 2002 ). There are limited therapeutic options for the treatment of this condition, which has a poor survival rate.

Adoptive immunotherapy has been shown to lengthen the time between resection and recurrence in patients with HCC (Takayama et al. 2000 ). Identifying potential cellular targets is important in developing strategies for treating cancer with this technique.

Gastrin is a peptide hormone which, in addition to stimulating gastric acid secretion, is also now believed to play a role in tumor growth. In addition to normal gut mucosa and brain, the receptor for gastrin (CCK-B/gastrin) is expressed in tumor cells including hepatic, gastrointestinal, and pancreatic cancers (Reubi et al. 1997 ; Watson et al. 1998 ; Caplin et al. 1999b ; Dockray 2000 ). These cancers also express gastrin and its precursor forms (Watson et al. 1998 ; Caplin et al. 1999b ; Dockray 2000 ), suggesting that gastrin may act in an autocrine fashion to stimulate cell growth (Dockray 2000 ). We have previously shown that the CCK-B/gastrin receptor is present in HCC and have demonstrated the expression of precursor forms of gastrin suggesting the existence of an autocrine pathway in this condition (Caplin et al. 1999b ). Gastrin and its precursor forms also promote growth of hepatocyte cell lines (Yao et al. 1995 ; Caplin et al. 2001 ). The specific CCK-B/gastrin receptor antagonist PD 135 caused inhibition of growth even in the absence of exogenous gastrin, supporting the idea of an autocrine loop (Caplin et al. 2001 ).

We have previously demonstrated that exposure of AR42J (pancreatic acinar carcinoma) cells to a labeled antibody (anti-CCK-BR) raised against the aminoterminus of the CCK-B/gastrin receptor results in translocation of the antibody, first to the cytoplasm and then to the nucleus (Savage et al. 1999 ). Nuclear localization of the CCK-B/gastrin receptor has been detected by immunoelectron microscopy (Caplin et al. 1999a ). Administration of anti-CCK-BR antibody increases apoptosis and necrosis in human colon tumors growing in nude mice (Watson et al. 2000 ).

The aims of this study were to detect the CCK-B/gastrin receptor in hepatoma cells and to determine whether uptake of an anti-CCK-BR antibody was able to induce apoptosis in these cells.


  Materials and Methods
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Cell lines
HepG2 (human HCC), WRL68 (human liver embryonic), HTC (rat hepatocellular carcinoma), PLC/PRF/5 (human HCC), and MCA RH 7777 (rat HCC) cells were obtained from the European Collection of Cell Cultures (ECACC; Porton Down, UK). NIH3T3 cells were a gift from Professor T. Matsui (Kobe University; Kobe, Japan).

Anti-CCK-BR Antibody
The anti-CCK-BR antibody (Aphton Corporation; Woodland, CA) was raised as previously described (Caplin et al. 1999a ). Briefly, the sequence of the immunizing peptide was KLNRSVQGTGPGPGASLSSPPPPC, comprising residues 5–21 of the CCK-B/gastrin receptor plus a seven-residue spacer. This was coupled to diphtheria toxin and injected into New Zealand White rabbits. Blood was collected after the third injection and the antibody was obtained from the serum by affinity purification.

Immunoblotting
Lysate corresponding to 10 µg protein was loaded onto 10% polyacrylamide minigels for SDS-PAGE. In addition to the liver cell lines, normal mouse fibroblast NIH3T3 cells were included as a negative control. After electrotransfer and overnight blocking, the membranes were incubated with 3 µg/ml anti-CCK-BR antibody. The antibody was used either untreated or had been preabsorbed for 48 hr with a molar excess of the immunizing peptide. After incubation with goat anti-rabbit/mouse biotin and streptavidin/biotin-peroxidase complex, labeling was revealed using diaminobenzidine (DAB) reagent.

Uptake and Apoptosis Studies
Anti-CCK-BR antibody was labeled with Alexa Fluor 488 fluorescent dye (Molecular Probes; Eugene, OR). Cells were cultured on chamber well slides and exposed to the labeled antibody (20 µg/ml) for 1 hr at 37C and fixed with buffered formaldehyde solution. Cells were then counterstained with a nuclear stain (propidium iodide) or for apoptosis using the TUNEL method.

For propidium iodide staining, slides were incubated with 100 µg/ml RNase for 90 min at 37C followed by 3 µg/ml propidium iodide (both in 2 x SSC) for 7 min.

Apoptosis staining used the TUNEL method (ApopTag Red in situ apoptosis detection kit; Intergen, Purchase, NY) which labels the 3'-OH ends of DNA fragments generated by apoptosis with chemically modified nucleotides. The latter are then detected using a secondary antibody conjugated to the fluorescent dye rhodamine. Images were obtained using either a confocal or fluorescence microscope with appropriate filters for the Alexa Fluor 488 and rhodamine/propidium iodide fluorescence.


  Results
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

In all hepatocyte cell lines except negative control NIH3T3 (normal mouse fibroblasts), anti-CCK-BR immunoreactivity was found by blotting. Specific bands were distinguished by the absence of a corresponding band in the blots incubated with the preabsorbed anti-CCK-BR antibody. A common band at ~162 kD was seen in all hepatocyte lines. Additional bands were seen at ~137 kD in WRL68, HepG2, and PLC/PRF/5 cells and at ~79 kD in the MCA RH7777 and HTC cells. A ~183-kD band was also observed with the MCA RH7777 cells. No specific bands were seen with the NIH3T3 cells (Fig 1).



View larger version (50K):
[in this window]
[in a new window]
 
Figure 1. Immunoblot of lysates from HepG2, WRL 68, PLC/PRF/5, MCA RH 7777, HTC, and NIH3T3 cell lines using anti-CCK-BR antibody either untreated (left panels, +) or preabsorbed with the immunizing peptide (right panels, -). Arrows with molecular weights in kD alongside indicate specific bands (HepG2, WRL68, PLC/PRF/5, MCA RH 7777, HTC) or molecular weight markers (NIH3T3).

Immunofluorescence microscopy demonstrated uptake of anti-CCK-BR in all five cell lines studied (Fig 2). In cells that displayed uptake, nuclear localization of antibody was observed in nearly 100% of PLC/PRF/5, WRL68, Hep G2, and HTC cells but could not be confirmed in MCA RH7777 cells. Using the immunofluorescent TUNEL assay, cells that showed anti-CCK-BR uptake were also found to be positive for apoptosis (Fig 3). No uptake was seen in any of the cell lines studied when exposed to Alexa Fluor 488-labeled non-immune rabbit antibody alone.



View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. Fluorescent micrographs obtained using confocal laser scanning microscopy showing Alexa Fluor 488-labeled anti-CCK-BR antibody uptake (A,D,G,J,M) and propidium iodide (PI) nuclear staining (C,F,I,L,O) in PLC/PRF/5 (A–C), HTC (D–F), HepG2 (G–I), WRL 68 (J–L), and MCA RH 7777 (M–O). The center panels (B,E,H,K,N) are a superimposition of the right-hand and left-hand panels. A single Z-section is shown for HepG2, PLC/PRF/5, WRL68, and HTC cells to emphasize the coincidence of anti-CCK-BR and propidium iodide staining, whereas a projection is given for the MCA RH 7777 cells. Bars = 10 µm.



View larger version (10K):
[in this window]
[in a new window]
 
Figure 3. Fluorescent micrographs showing PLC/PRF/5 (A–C), HTC (D–F), HepG2 (G–I), WRL68 (J–L), and MCA RH 7777 (M–O) cells displaying Alexa Fluor 488-labeled anti-CCK-BR antibody uptake (A,D,G,J,M) and apoptosis (C,F,I,L,O). Coincidence of anti-CCK-BR and apoptosis fluorescence is indicated by the yellow/orange color in the center panels (B,E,H,K,N). Bar = 20 µm.


  Discussion
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

We have demonstrated that immunodetectable CCK-B/gastrin receptor is present in hepatic tumor and embryonic liver cells but not in normal fibroblasts. We have also shown that anti-CCK-BR antibody is internalized by these cells and that there was an association with apoptosis.

Watson et al. 1998 reported sizes of 40 and 70 kD for the CCK-B receptor using immunoblotting. Here we have found higher molecular weights for the receptor in the hepatocyte cell lines. This discrepancy could be due to differences in glycosylation of the CCK-B receptor molecule, resulting possibly from variation in cell lysate preparation. Larger CCK-B/gastrin receptor sizes of 74 and 115 kD have been reported by other workers (Matsumoto et al. 1987 ; Morisset et al. 2000 ).

Although we observed an association of uptake of labeled anti-CCK-BR antibody and apoptosis in all five hepatocyte cell lines examined, we did not observe nuclear uptake in the MCA RH7777 cells. This suggests that nuclear uptake of the antibody may not be essential for inducing apoptosis.

We do not know if the translocation to the nucleus involves the entire receptor or a fragment of the receptor. Ligand-induced internalization of the CCK-B receptor was demonstrated by Pohl et al. 1997 . Deletion of the carboxyl terminus resulted in decreased endocytosis, as did mutation of serine and threonine residues in this region. However G-protein coupling and ligand-stimulated Ca2+ efflux were unaffected by mutation, suggesting that the internalization mechanism is distinct from that involved in stimulus secretion coupling.

Crosslinking of cell surface Fas molecules mediated by binding of either Fas ligand or anti-Fas antibody leads to apoptosis (Nagata and Golstein 1995 ; Wallach et al. 1999 ). By analogy, crosslinking of CCK-BR by antibody may be the trigger for apoptosis in the cell lines studied here. Alternatively, the occurrence of receptor endocytosis in the absence of ligand-induced secondary messenger production may be the signal for apoptosis. Recently, the existence of dependence receptors has been postulated in both cancer and neuronal development (Mehlen and Bredesen 2000 ). Such receptors have a dual function. In the presence of the appropriate ligand, they initiate a signal for proliferation or differentiation. In the absence of ligand, a signal for cell death by apoptosis is generated (Mehlen and Bredesen 2000 ). The association of antibody uptake and apoptosis demonstrated here could be explained by this hypothesis if CCK-BR existed as a dependence receptor in tumor cells. In this scenario, gastrin produced by the tumor cells would act in an autocrine fashion on the CCK-BR to cause proliferation. By contrast, binding of anti-CCK-BR antibody would mimic an absence of ligand and lead to cell death by apoptosis. If this hypothesis could be proved to exist in hepatic and other cancers, this could have major implications for their treatment.

In summary, this study has demonstrated CCK-B/gastrin receptor expression in hepatocyte cell lines and that binding and uptake of anti-CCK-BR antibody is associated with apoptosis. The therapeutic options for hepatocellular carcinoma are very limited and further studies are ongoing to determine whether the findings of this study can be applied in vivo and subsequently in human subjects.


  Acknowledgments

Supported by a research grant from Aphton Corporation.

Received for publication November 26, 2001; accepted March 22, 2002.


  Literature Cited
Top
Summary
Introduction
Materials and Methods
Results
Discussion
Literature Cited

Caplin ME, Clarke P, Grimes S, Dhillon AP, Khan K, Savage K, Lewin J et al. (1999a) Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy. Regul Peptides 84:81-89[Medline]

Caplin ME, Khan K, Grimes S, Micheali D, Savage K, Pounder RE, Dhillon AP (2001) Effect of gastrin and anti-gastrin antibodies on proliferation of hepatocyte cell lines. Dig Dis Sci 46:1356-1366[Medline]

Caplin ME, Khan K, Savage K, Rode J, Varro A, Micheali D, Grimes S et al. (1999b) Expression of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. J Hepatol 30:519-526[Medline]

Dockray GJ (2000) Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Gut 47:747-748[Free Full Text]

Matsumoto M, Park J, Yamada T (1987) Gastrin receptor characterization: affinity cross-linking of the gastrin receptor on canine gastric parietal cells. Am J Physiol 252:G143-147[Abstract/Free Full Text]

Mehlen P, Bredesen DE (2000) Les récepteurs à dépendance: interface entre apoptose, développement du système nerveux et contrôle de la tumorigenèse. Bull Cancer 87:537-541[Medline]

Morisset J, Wong H, Walsh JH, Laine J, Bourassa J (2000) Pancreatic CCK(B) receptors: their potential roles in somatostatin release and delta-cell proliferation. Am J Physiol 279:G148-156[Abstract/Free Full Text]

Nagata S, Golstein P (1995) The Fas death factor. Science 267:1449-1456[Medline]

Nair S, Shivakumar KS, Thuluvath PJ (2002) Mortality from hepatocellular and biliary cancers: changing epidemiological trends. Am J Gastroenterol 97:167-171[Medline]

Pohl M, Silvente–Poirot S, Pisegna JR, Tarasova NI, Wank SA (1997) Ligand-induced internalization of cholecystokinin receptors. Demonstration of the importance of the carboxyl terminus for ligand-induced internalization of the rat cholecystokinin type B receptor but not the type A receptor. J Biol Chem 29:18179-18184

Reubi JC, Schaer J-C, Waser B (1997) Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res 57:1377-1386[Abstract]

Savage K, Khan K, Dhillon AP, Grimes S, Micheali D, Brett B, Pounder RE et al. (1999) Trafficking of CCK-B/gastrin receptor in tumour cells using confocal microscopy. Gastroenterology 116:G2801

Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, Shimada K et al. (2000) Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 356:802-807[Medline]

Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP (1999) Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331-367[Medline]

Watson SA, Clarke PA, Morris TM, Caplin ME (2000) Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor. Cancer Res 60:5902-5907[Abstract/Free Full Text]

Watson SA, Clarke P, Smith A, Varro A, Micheali D, Grimes S, Caplin ME et al. (1998) Expression of CCKB/gastrin isoforms in gastro-intestinal tumour cells. In J Cancer 77:572-577

Yao CZ, Bold RJ, Ishizuka J, Townsend CM, Jr, Thompson JC (1995) Growth of mouse hepatocytes is stimulated by gastrin. J Cell Physiol 163:532-537[Medline]





This Article
Abstract
Full Text (PDF)
Alert me when this article is cited
Alert me if a correction is posted
Citation Map
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Google Scholar
Articles by Stubbs, M.
Articles by Caplin, M. E.
Articles citing this Article
PubMed
PubMed Citation
Articles by Stubbs, M.
Articles by Caplin, M. E.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]